Targeted Therapies in Gastric Cancer: Molecular Signatures and Immune Microenvironment Insights

  • 4,127

    Total downloads

  • 12k

    Total views and downloads

About this Research Topic

Background

Despite the constant decline in incidence, gastric cancer (GC) accounts for 4% of all neoplasms in Europe, being the sixth-ranked cancer for incidence (13.7 cases/100,000 individuals) and the fourth for mortality (10.3 deaths/100,000 individuals). GC is widely represented in both sexes as the fifth incident neoplasm among men (19.5 cases/100,000) and the seventh among women (9.3 cases/100,000). Occurrence is characterized by considerable geographical variation, which allows us to distinguish countries with high, intermediate, and low incidence. The incidence also varies with age and peaks in the seventh decade. Beside the overall reduction in incidence, a relative increase in primitive forms with a proximal location is observed, particularly for those arising from the gastroesophageal junction. In Europe, the 5-year survival rate for patients diagnosed with GC is around 25%.

GC is a histologically, molecularly, and immunologically heterogeneous disease. Several targeted therapeutics have been developed for the treatment of unresectable or metastatic GC. Comprehensive characterization of the molecular profile and the tumor immune microenvironment of GC has allowed researchers to explore promising biomarkers for GC treatment. Recently, molecular characterization via “The Cancer Genome Atlas” project has identified 4 subtypes of gastric adenocarcinoma: Epstein-Barr virus (EBV)-positive subtype, microsatellite instability subtype, genomically stable subtype, and chromosomal instability subtype. The subgroup of EBV-positive tumors presents amplification of JAK2, CD274, and PDCD1LG2 genes. CD274 and PDCD1LG2 encode PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2), suggesting a role for PD-1/PD-L1 inhibitors. This has enabled a new paradigm in precision-targeted immunotherapy.

As a biomarker, PD-L1 displays some limitations which may affect its usefulness as a predictor of response to immunotherapy. One of these limitations is the intratumoral heterogeneity of PD-L1 expression. Indeed, PD-L1 expression shows a high rate of discordance between biopsy and surgically resected tissue, and between primary and metastatic tumors. Temporal heterogeneity of PD-L1 expression between tumors before and after chemotherapy has also been reported. Another major limitation is interobserver variation in the assessment of PD-L1 expression. These discrepancies occur even among experienced pathologists. Therefore, standardized and objective methods for assessing PD-L1, such as using artificial intelligence in image analysis, are urgently needed. At the same time, the presence and distribution of tumour-infiltrating lymphocytes (TILs) is a critical biomarker that can be assessed in concert with PD-L1. A high density of TILs and increased CD3+ or CD8+ T cells are associated with a favorable prognosis in patients with GC. Also, the distribution pattern of TILs is crucial for predicting PD-L1 immunotherapy response in various tumors. The concept of three immune phenotypes has been suggested based on the state of TIL distribution in tumors or in the peritumoral stroma: inflamed (TILs localized intratumorally), excluded (TILs retained in the peritumoral stroma), and desert (TILs scattered in both tumor nests and in the stroma). Tumors with an inflamed phenotype showed increased expression of PD-L1 by tumor and immune cells and a better response to ICI treatment compared to other phenotypes. The number of TILs, immune cell subtypes, and their distribution are important factors associated with prognostic significance and may be predictive markers of immunotherapy response.

Understanding the mechanisms of biomarkers, the current diagnostic methods and their limitations, and the implications for targeted therapy response are crucial aspects in precision medicine. A comprehensive examination of these biomarkers in GC can provide better patient stratification and selection, allowing them to benefit from specific targeted therapies, including immunotherapy.

We invite the submission of research articles that may help clarify the mechanisms underlying tumor heterogeneity/microenvironment, the diverse molecular signatures of GC, and the relative contribution of immune system cells. Studies conducted to unveil the molecular alterations exhibited by tumor cells, the proposal of novel targets for cancer therapy, and the mechanisms of action of drugs and drug candidates (including off-target effects and drug repurposing) are also welcome. In addition, we aim to promote the diffusion of review articles highlighting new findings in the above areas and underlining the similarities or cross-comparisons between GC and other human malignancies.



Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by robust and relevant validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this topic.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Classification
  • Clinical Trial
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Gastric cancer, tumor microenvironment, tumor immune microenvironment, tumor-infiltrating lymphocytes, immunotherapy, immune checkpoint inhibitors, classification, immunogenomic, profiling

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Participating Journals

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 12kTopic views
  • 7,769Article views
  • 4,127Article downloads
View impact